ExonHit Therapeutics have announced that a number of its SpliceArray products are now available on the Affymetrix microarray platform. This announcement follows the supply and provider agreement ...
Genetic products company, Affymetrix Inc. (AFFX), inked a ‘Powered by Affymetrix’ (“PbA”) Program agreement with Korea-based biotechnology company, DNA Link Inc. Following the terms of the deal, DNA ...
Offerings Now Encompass Multiplex and Parallel Analysis of Cells, Proteins, and Genes Affymetrix, best known for its pioneering work in commercializing microarrays for gene expression research since ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix (Nasdaq:AFFX) and Ariosa Diagnostics, Inc. today announced the signing of a multi-year supply agreement covering Affymetrix arrays and instruments to ...
Affymetrix Inc. announced that the US Food and Drug Administration (FDA) has granted regulatory clearance to its GCS3000Dx (GCSDx) platform for in vitro gene expression diagnostic testing. The ...
VICTORIA, BC, Sept. 5 /PRNewswire/ - GenoLogics, a leading developer oflab and data management software solutions for life sciences research,announced today the Company has joined the Affymetrix ...
SANTA CLARA, USA: Affymetrix, Inc. announced a co-marketing agreement naming GenoSplice, Inc. as its preferred data analysis service provider for the new GeneChip Human Transcriptome Array 2.0, a ...
Microarray technologies are generating new data at a breathtaking speed. Because of the sheer size of these data and the technical complexity involved in microarray chip designs, it is a challenge to ...
Research and Markets (http://www.researchandmarkets.com/research/7fhv5g/the_world_market) has announced the addition of the "The World Market for Microarrays" report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback